Danaher Corp. (DHR) News

Danaher Corp. (DHR): $297.49

-0.14 (-0.05%)

POWR Rating

Component Grades













Filter DHR News Items

DHR News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

DHR News Highlights

  • 500 - Internal server error
  • Over the past 29 days, the trend for DHR's stories per day has been choppy and unclear. It has oscillated between 1 and 22.
  • The most mentioned tickers in articles about DHR are BEAM, CONE and AAPL.

Latest DHR News From Around the Web

Below are the latest news stories about Danaher Corp that investors may wish to consider to help them evaluate DHR as an investment opportunity.

Top Ranked Momentum Stocks to Buy for July 28th

CROX, ISRG, MIDD, and DHR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 28, 2021

Yahoo | July 28, 2021

Looking for Multi-Sector Conglomerates Stocks? The Zacks Rank Can Help You Find Winners

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.

Yahoo | July 28, 2021

Here's How Much a $1000 Investment in Danaher Made 10 Years Ago Would Be Worth Today

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Yahoo | July 28, 2021

5 Top-Ranked Momentum Picks Using Driehaus Strategy

DHR, CLFD, HCA, FBP, and SNBR qualified as the day's Momentum Picks Using Driehaus Strategy.

Yahoo | July 28, 2021

Danaher company Pall Corporation in $1.5B capacity expansion plan with Cytiva

Delmaine Donson/E+ via Getty Images Pall Corporation, a unit of Danaher (DHR), and Cytiva announced an ongoing strategic growth plan to spend over $1.5B for the expansion of manufacturing capacity and services for global life sciences customers across the globe. The investments are incremental to previously announced investments and follow five...

Seeking Alpha | July 27, 2021

Danaher (DHR) is a Top-Ranked Momentum Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Yahoo | July 27, 2021

Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutions

An ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher (NYSE: DHR) Corporation, will expand manufacturing capacity and services across geographies for global life sciences customers.

Yahoo | July 27, 2021

Top Stock Reports for Apple, Danaher & Novartis

Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Danaher (DHR), and Novartis (NVS).

Yahoo | July 26, 2021

Beckman Coulter to Distribute BNP Cardiac Assay to Customers

Beckman Coulter, a global clinical diagnostics leader, today announced that it has entered into definitive agreements with Quidel Corporation to obtain all rights related to the manufacture, distribution, and sale of a BNP assay for Beckman Coulter analyzers. Under the terms of the agreements, Quidel will continue to manufacture and supply certain components to Beckman Coulter related to the assay, and Beckman Coulter will exclusively manufacture and sell to customers the BNP assay currently sol

Yahoo | July 26, 2021

Digital Pathology Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Danaher Corporation, Digipath, Glencoe Software, Hamamatsu Photonics, Indica Labs, Koninklijke

This report studies the Digital Pathology Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Digital Pathology market segmented by company, region, type []

Jumbo News | July 25, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7748 seconds.